U.S. DXM and Codeine Syrup Market Analysis: Increasing Focus on Prescription Respiratory Therapeutics and Cough Management
The United States represents a major share of the DXM and Codeine Syrup Market, driven by the high prevalence of seasonal respiratory infections, chronic cough conditions, and well-established healthcare infrastructure. Rising cases of influenza, bronchitis, and COPD continue to support demand for effective cough suppressant therapies. The global DXM and Codeine Syrup Market is projected to...
0 Comments 0 Shares 348 Views 0 Reviews